{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:54:20Z","timestamp":1793246060148,"version":"4.5.0"},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,12,21]],"date-time":"2005-12-21T00:00:00Z","timestamp":1135123200000},"content-version":"vor","delay-in-days":2577,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clinic Periodontology"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> The release profile of chlorhexidine from the PerioChip<jats:sup>TM<\/jats:sup> (Chip), a biodegradable local delivery system that contains 2.5 mg of chlorhexidine gluconate (CHX) in a cross\u2010linked hydrolyzed gelatin matrix, into the gingival crevice, was evaluated in an in vivo, open label, single\u2010center. 10\u2010day pharmacokinetic study conducted on 19 volunteers with chronic adult periodontitis. Each volunteer had a single chip inserted into each of 4 selected pockets, with probing pocket depths of between 5\u20138 mm. at time 0. Gingival crevicular fluid (GCF) samples were collected using filter paper strips prior to Chip placement and at 2 h, 4 h, 24 h and 2, 3, 4, 5, 6, 8, and 9 days post\u2010Chip placement. The GCF volume was measured using a calibrated Periotron<jats:sup>TM<\/jats:sup> 6000. Blood samples were collected at times 0, 1, 4, 8, 12 h and 5 days post\u2010dosing. Urine was collected as a total 24\u2010h specimen immediately post\u2010dosing and 2 single samples at time 0, prior to dosing, and 5 days. The CHX was eluted from the paper strips and the CHX levels in GCF. blood and urine quantified using HPLC. The results indicate an initial peak concentration of CHX in the GCF at 2 h post\u2010Chip insertion (2007 \u03bc\/ml) with slightly lower concentrations of between 1300\u20131900 \u03bcg\/ml being maintained over the next 96 h. The CHX concentration then progressively decreased until study conclusion with significant CHX concentrations (mean=57 \u03bcg\/ml) still being detectable at study termination. CHX was not detectable in any of the plasma or urine samples at any time point during the study. These results indicate that the PerioChip<jats:sup>TM<\/jats:sup> can maintain clinically effective levels of CHX in the GCF of periodontal pockets for over 1 week with no detectable systemic absorption.<\/jats:p>","DOI":"10.1111\/j.1600-051x.1998.tb02407.x","type":"journal-article","created":{"date-parts":[[2005,12,21]],"date-time":"2005-12-21T08:19:33Z","timestamp":1135153173000},"page":"1017-1021","source":"Crossref","is-referenced-by-count":76,"title":["An in vivo Study of the chlorhexidine release profile of the PerioChip<sup>TM<\/sup> in the gingival crevicular fluid, plasma and urine"],"prefix":"10.1111","volume":"25","author":[{"given":"W. A.","family":"Soskolne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Chajek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Flashner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stabholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kolatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. I.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,21]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1967.38.1.36"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)83482-9"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1986.0118"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1981.52.9.545"},{"key":"e_1_2_1_6_1","first-page":"115","volume-title":"Medical applications of controlled release","author":"Goodson J. M.","year":"1984"},{"key":"e_1_2_1_7_1","first-page":"1625","article-title":"Pharmacokinetic principles controlling efficacy of oral therapy","volume":"68","author":"Goodson J. M.","year":"1989","journal-title":"Journal of Denial Research"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1992.63.2.118"},{"key":"e_1_2_1_9_1","article-title":"Adjunctive use of a subgingival controlled\u2010release chlorhexidine chip (PerioChipTM) reduces probing pocket depth and improves attachment level compared with scaling and root planing alone","volume":"69","author":"Jeffcoat M. K.","year":"1998","journal-title":"Journal of Periodontology"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1993.64.8s.782"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.1976.tb00061.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1985.56.8.447"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01020.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(94)90033-7"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/iai.42.2.510-515.1983","article-title":"Bacteriology of moderate (chronic) periodontitis in mature adult humans","volume":"42","author":"Moore W. E. C.","year":"1983","journal-title":"Infection and Immunity"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1986.tb01435.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1979.50.6.301"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1979.tb01935.x"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345700490020401"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1902\/jop.1997.68.1.32","article-title":"Sustained local delivery of chlorhexidine (Perio Chip) as an adjunct to scaling and root planing in the treatment of periodontal disease: a multicenter study","volume":"68","author":"Soskolne W. A.","year":"1997","journal-title":"Journal of Periodontology"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1989.tb01651.x"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1991.tb02315.x"}],"container-title":["Journal of Clinical Periodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-051X.1998.tb02407.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-051X.1998.tb02407.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:00:42Z","timestamp":1698472842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-051X.1998.tb02407.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1111\/j.1600-051X.1998.tb02407.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-051x.1998.tb02407.x","archive":["Portico"],"relation":{},"ISSN":["0303-6979","1600-051X"],"issn-type":[{"value":"0303-6979","type":"print"},{"value":"1600-051X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}